Formic Acid

Formic Acid

SCHEMBL3746258

CN1CCN(C(C(=O)NNc2cc(Cl)cc(Cl)c2)c2ccc3sccc3c2)CC1.O=CO

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.43
CCR3 P51677 2/20 0.39
ALDH1A1 P00352 4/20 0.37
LMNA P02545 1/20 0.37
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3637462 0.96 GHSR (0.46) GHSRCCR3ALDH1A1LMNAMEN1
Formic Acid SCHEMBL3737845 0.86 GHSR (0.49) GHSRCCR3ALDH1A1LMNAMEN1
Formic Acid SCHEMBL3745969 0.83 GHSR (0.45) GHSRCCR3ALDH1A1LMNAKDM4E
SCHEMBL3639856 0.81 GHSR (0.52) GHSRCCR3ALDH1A1LMNAMEN1
Formic Acid SCHEMBL3741661 0.80 GHSR (0.47) GHSRCCR3ALDH1A1LMNAMEN1
SCHEMBL3639648 0.79 CLK1 (0.46) GHSRCCR3ALDH1A1LMNAMEN1
SCHEMBL3640849 0.79 GHSR (0.48) GHSRCCR3ALDH1A1LMNAKDM4E
SCHEMBL3638220 0.78 GHSR (0.53) GHSRCCR3ALDH1A1LMNAMEN1
Formic Acid SCHEMBL3746598 0.78 GHSR (0.49) GHSRCCR3ALDH1A1LMNAMEN1
SCHEMBL3743236 0.77 GAA (0.55) GHSRALDH1A1LMNAKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US claimed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R GHSR 2/4885CCR3 3769/4885ALDH1A1 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.